ReviewFrontiers in medicine2025
Optical properties of artificial intraocular lenses and considerations for additive manufacturing.
Review in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cataracts, a leading cause of blindness in the world, are commonly treated by replacing the ocular lens with an artificial intraocular lens (IOL). The material and structure of the IOL are major factors in their efficacy, affecting, among other characteristics, the optics of the eye. In the recent research record, two optical properties have emerged as standardized characterization methods for IOL optics: (1) optical transmittance and (2) optical scattering. This mini review describes these two methods and collates data in such a way that comparisons may be drawn across four different IOL material types (PMMA, hydrophobic acrylic, hydrophilic acrylic, and silicone) and three IOL conditions (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.